General
Preferred name
PIOGLITAZONE HYDROCHLORIDE
Synonyms
U-72107E ()
Pioglitazone (hydrochloride) ()
U 72107A ()
AD 4833 ()
Pioglitazone HCl ()
AD-4833, U-72107E ()
Actos ()
Pioglitazone (as hydrochloride) ()
Piomed ()
Diabiom ()
Glizofar ()
NSC-758876 ()
Glidipion ()
STR-001 ()
U-72107A ()
P&D ID
PD001166
CAS
111025-46-8
112529-15-4
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Antidiabetic
First approval
1999
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Selective PPARgamma agonist; antidiabetic agent (Tocriscreen Plus)
DESCRIPTION Selective, high affinity PPARalpha agonist (Tocris Bioactive Compound Library)
Compound Sets
13
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Selleckchem Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
External IDs
24
Properties
(calculated by RDKit )
Molecular Weight
392.1
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
3
Aromatic Ring Count
2
cLogP
3.58
TPSA
68.29
Fraction CSP3
0.32
Chiral centers
1.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Nuclear Receptors
Primary Target
PPAR?
MOA
Agonist
Target
PPAR? agonist
Ferroptosis
PPAR
Ferroptosis,P450 (e.g. CYP17),PPAR
Pathway
Apoptosis
Cell Cycle/DNA Damage
Vitamin D Related/Nuclear Receptor
Source data